Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

NCT05268783 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT05268783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05268783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
November 5, 2018
Completion date
December 31, 2029
Enrollment
1,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

quality of life